23AndMe is a Google-funded maker of a $99 genetic test designed to tell if people are at risk for certain health conditions. Insurers are concerned the test could lead to increased care, whether it be needed or not, that they would have to pay for.
NOT FOR REPRINT
Why 23AndMe terrifies health insurance companies
By
staff Writer
November 26, 2013 at 11:08 AM
Share & Print
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
